Latigo Biotherapeutics, Inc. Common Stock (LTGO) stock: key figures, P/E, revenue and dividend
Health Care · United States
Latigo Biotherapeutics, Inc. Common Stock financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 USD | 0.00 USD |
| Operating income | -63.45 m USD | -110.39 m USD |
| EBIT | -63.45 m USD | -110.39 m USD |
| Net income | -61.18 m USD | -109.17 m USD |
| Diluted EPS – continuing operations | -1.02 USD | -1.81 USD |
Full history since 2024, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Latigo Biotherapeutics, Inc. Common Stock
Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction. The company's pipeline includes LTG-001, an oral NaV1.8 inhibitor designed to provide fast-acting, opioid-sparing relief for the treatment of acute pain; LTG-321, a NaV1.8 inhibitor candidate developed for the treatment of chronic musculoskeletal pain, starting with osteoarthritis; and LTG-418, a NaV1.8 inhibitor developed for the treatment of acute and chronic pain. Latigo Biotherapeutics, Inc. was formerly known as WVB-Desmond, Inc. and changed its name to Latigo Biotherapeutics, Inc. in March 2019. Latigo Biotherapeutics, Inc. was incorporated in 2018 and is based in Thousand Oaks, California.
More stocks
- Chongqing Constr Engineering (600939.SS)
- QITIAN Technology Group Co Ltd (300061.SZ)
- Pexip Holding ASA (PEXIP.OL)
- NICE Information Service Co. Ltd (030190.KS)
- Arteris, Inc. (AIP)
- Tinexta S.p.a (TNXT.MI)
- Guangdong Dongpeng Holdings (003012.SZ)
- BlackSky Technology Inc. (BKSY)
- PSI Software (PSAN.DE)
- Inesa Intelligent Tech Inc B (900901.SS)
- MANITOWOC CO INC (MTW)
- BMC Medical Co. Ltd. A (301367.SZ)
Not investment advice. All data without warranty, price as of 02.11.2026. Details in the risk notice.